Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Germany”
- A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adult Male Subjects With Cerebral AdrenoleukodystrophyActive Not Recruiting
Sponsor: Minoryx Therapeutics, S.L.
Cerebral Adrenoleukodystrophy (cALD)
United States, Argentina, Brazil, France, Germany +3 more
- HAELO: A Phase 3 Study to Evaluate NTLA-2002 in Participants With Hereditary Angioedema (HAE)Active Not Recruiting
Sponsor: Intellia Therapeutics
Hereditary Angioedema
United States, Australia, Canada, France, Germany +4 more
Sponsor: Viatris Innovation GmbH
Systemic Lupus Erythematosus
United States, Bulgaria, Chile, Czechia, France +19 more
Sponsor: Ipsen
Cervical Dystonia
United States, Czechia, France, Germany, Italy +3 more
Sponsor: GlaxoSmithKline
Pulmonary Disease, Chronic Obstructive
United States, Australia, Bulgaria, Canada, China +8 more
- A Phase I/II Study of DYP688 in Patients With Metastatic Uveal Melanoma and Other GNAQ/11 Mutant MelanomasActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Metastatic Uveal Melanoma
United States, Australia, France, Germany, Netherlands +2 more
Sponsor: Sanofi
Immunoglobulin G4 Related Disease
United States, Argentina, Belgium, Canada, Chile +14 more
Sponsor: University of Cologne
Polycystic Kidney, Autosomal Dominant
Austria, Germany, Netherlands, Spain
- A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus ErythematosusActive Not Recruiting
Sponsor: Viatris Innovation GmbH
Lupus Erythematosus, Systemic
United States, Chile, Czechia, Georgia, Germany +13 more
- FARAPULSE Workflow Assessment RegistryActive Not Recruiting
Sponsor: Boston Scientific Corporation
Atrial Fibrillation (AF)
Austria, Belgium, France, Germany, Greece +5 more
Sponsor: Ipsen
Moderate to Severe Glabellar Lines
United States, France, Germany, Japan
Sponsor: Spyre Therapeutics, Inc.
Ulcerative Colitis · Inflammatory Bowel Diseases · Colitis · Colitis, Ulcerative
United States, Argentina, Australia, Austria, Belgium +30 more
- Artificial Intelligence(AI) in the Emergency Department (ED) in CologneActive Not Recruiting
Sponsor: University of Cologne
Emergency Care · Clinical Decision Support · Triage
Germany
- Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung DiseaseEnrolling By Invitation
Sponsor: United Therapeutics
Idiopathic Pulmonary Fibrosis · Interstitial Lung Disease · Progressive Pulmonary Fibrosis
United States, Argentina, Australia, Belgium, Canada +13 more
- A Registry on the FARAVIEW Technology of the OPAL HDx Mapping System When Used With the FARAWAVE NAV Ablation Catheter in the Treatment of Atrial FibrillationActive Not Recruiting
Sponsor: Boston Scientific Corporation
Atrial Fibrillation · Pulsed Field Ablation · FARAPULSE
Austria, France, Germany, Greece, Ireland +5 more
Sponsor: Novo Nordisk A/S
Cardiovascular Risk · Chronic Kidney Disease · Inflammation
United States, Argentina, Australia, Belgium, Brazil +33 more
- Frequency of Selected Single Nucleotide Polymorphisms in Huntington Disease Gene Expansion CarriersCompleted
Sponsor: Hoffmann-La Roche
Huntington Disease
United States, Argentina, Australia, Canada, Denmark +7 more
Sponsor: AstraZeneca
Systemic Sclerosis · Idiopathic Inflammatory Myopathies · Rheumatoid Arthritis
United States, Australia, Germany, Spain, Sweden +1 more
- Long-term Safety and Efficacy of Efanesoctocog Alfa (BIVV001) in Previously Treated Patients With Hemophilia AActive Not Recruiting
Sponsor: Bioverativ, a Sanofi company
Hemophilia A
United States, Argentina, Australia, Belgium, Brazil +18 more
- Rollover Study for Continued Safety and Tolerability in Subjects Treated With Spartalizumab Alone or in Combination With Other Study TreatmentsActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Advanced Solid Tumors
United States, Belgium, Canada, China, Czechia +12 more
Sponsor: Ipsen
Spasticity
United States, Austria, Bulgaria, Czechia, France +9 more
- A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)Enrolling By Invitation
Sponsor: Taiho Oncology, Inc.
Acute Myeloid Leukemia · Chronic Myelomonocytic Leukemia · Myelodysplastic Syndromes
United States, Armenia, Austria, Bulgaria, Canada +8 more
Sponsor: Ipsen
Episodic Migraine · Chronic Migraine
United States, Australia, Brazil, Canada, Czechia +9 more
Sponsor: Boehringer Ingelheim
Bronchiectasis
United States, Australia, Belgium, Bulgaria, Canada +18 more
Sponsor: Merck Sharp & Dohme LLC
Hodgkin Disease · Lymphoma, Non-Hodgkin · Lymphoma, B-Cell
United States, Australia, Canada, Germany, Israel +1 more